Συγγραφείς:
Navrkalova, V.
Young, E.
Baliakas, P.
Radova, L.
Sutton, L.-A.
Plevova, K.
Mansouri, L.
Ljungström, V.
Ntoufa, S.
Davis, Z.
Juliusson, G.
Smedby, K.E.
Belessi, C.
Panagiotidis, P.
Touloumenidou, T.
Davi, F.
Langerak, A.W.
Ghia, P.
Strefford, J.C.
Oscier, D.
Mayer, J.
Stamatopoulos, K.
Pospisilova, S.
Rosenquist, R.
Trbusek, M.
Λέξεις-κλειδιά:
ATM protein; B lymphocyte receptor; ATM protein; ATM protein, human, cancer classification; cell proliferation; chronic lymphatic leukemia; controlled study; cytogenetics; gene frequency; gene mutation; gene rearrangement; genetic association; genetic disorder; genetic variability; human; Letter; major clinical study; multicenter study (topic); mutation rate; sequence analysis; telomere homeostasis; telomere shortening; time to treatment; chronic lymphatic leukemia; classification; clinical trial; cohort analysis; DNA sequence; genetics; mortality; multicenter study; mutation; survival analysis; telomere; ultrastructure, Ataxia Telangiectasia Mutated Proteins; Cohort Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Sequence Analysis, DNA; Survival Analysis; Telomere; Telomere Shortening
